FX.co - Establishment Labs Jumps In Pre-market On FDA Approval Of Its Motiva Breast Implants

2024-09-27T14:04:00

Establishment Labs Jumps In Pre-market On FDA Approval Of Its Motiva Breast Implants

Shares of Establishment Labs Holdings Inc. (ESTA) jumped more than 21% in pre-market trading on Friday, reaching $50.22, following the U.S. Food and Drug Administration's approval of its Motiva breast implants.

According to a company statement, the Motiva implants, which include the Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round models, are engineered to improve biocompatibility and minimize inflammation.

On Thursday, Establishment Labs' stock closed at $41.19, marking a 3.25% increase. Over the past year, the stock has fluctuated between $16.96 and $60.12.

*The market analysis posted here is meant to increase your awareness, but not to give instructions to make a trade

FX.co ★ Establishment Labs Jumps In Pre-market On FDA Approval Of Its Motiva Breast Implants

Forex News

Establishment Labs Jumps In Pre-market On FDA Approval Of Its Motiva Breast Implants